FMC posts earnings, says UK omega-3s facility nearing full scale production

By Hank Schultz

- Last updated on GMT

FMC said its Seal Sands omega-3s production facility will start shipping products in the first quarter of 2014.
FMC said its Seal Sands omega-3s production facility will start shipping products in the first quarter of 2014.
FMC Corporation announced a 24% rise in revenues in its fourth quarter of 2013, hitting $1.1 billion. For the full year of 2013, the company hit $3.9 billion in revenues, a 14% rise over the previous year. In its earnings release, FMC gave an update on the progress of its Seal Sands omega-3 production facility.

The nutrition segment contributed $189.8 million to fourth quarter revenue, repenting a 13% rise year-over-year. Segment earnings of $40.4 million were also 13 percent higher than the prior-year quarter despite operational disruptions related to two natural disasters near the company's Cebu facility in the Philippines.  Business growth was primarily driven by higher volumes of colloidal microcrystalline cellulose and pharmaceutical binders.  Earnings growth was lower than previous guidance due to a delayed startup of the Seals Sands omega-3 production facility which is located in a chemical industry park in northeastern England.  The plant, which was part of FMC’s $345 million purchase of fish oils refiner EPAX last year, is back on track with final testing and regulatory approvals expected to be completed in February 2014 with initial sales expected in the first quarter. 
In addition to nutritional products, FMC, based in Philadelphia, is active in agricultural products and services, which generate the lion’s share of the company’s revenues, and minerals.

Related news

Related products

show more

Gemini Pharmaceuticals Quality Partnership Program

Gemini Pharmaceuticals Quality Partnership Program

Gemini Pharmaceuticals | 09-Oct-2017 | Technical / White Paper

A Brand Owner/Own Label Distributor is 100% responsible for the quality of their products - not the Contract Manufacturing Organization. This is exactly...

Resveratrol – Revitalizing Cognitive Function

Resveratrol – Revitalizing Cognitive Function

Evolva | 29-Sep-2017 | Technical / White Paper

Cognitive decline is fast becoming the biggest concern of the 65+ population. A population which is set to reach 1.1 billion by 2030*.  · 80% of 60+ take...

Product Cost Reduction Strategies for the Brand Owner

Product Cost Reduction Strategies for the Brand Owner

Gemini Pharmaceuticals | 11-Sep-2017 | Technical / White Paper

Brand Owners are feeling product price pressure from all corners these days. Consumers are demanding more of the products they buy and want them at a lower...

NattoPharma

12 Reasons MenaQ7® is the Superior Vitamin K2

NattoPharma USA, Inc. | 11-Sep-2017 | Data Sheet

Vitamin K2 as MK-7 supplements are truly changing the face of global health, benefiting old and young alike. We know this because NattoPharma has single-handedly...

Related suppliers